Press briefing on EU recommendation for COVID-19 Vaccine AstraZeneca
EventHumanCOVID-19Vaccines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Date
- Friday, 29 January 2021, All day
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
Event summary
This virtual press briefing will discuss the outcome of the evaluation of COVID-19 Vaccine AstraZeneca by EMA’s human medicines committee (CHMP).
Speakers include:
- Emer Cooke (EMA's Executive Director)
- Bruno Sepodes (CHMP Vice-chair)
- Sabine Straus (PRAC Chair)
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy).
Marie-Agnes Heine, EMA's Head of Communication, will moderate the press briefing.
The press briefing is held in English.